Shaanxi Kelong New Material Technology
920098
Sprint Precision Technologies
688605
Shandong Boyuan Pharmaceutical&Chemical
301617
SHENG YE ELECTRIC
920128
Chengdu Jiachi Electronic Technology
688708
CN Stock MarketDetailed Quotes
601339 Bros Eastern Co.,Ltd
- 5.61
- 0.000.00%
Not Open Dec 12 09:30 CST
8.41BMarket Cap23.09P/E (TTM)
0.00High0.00Low0lotVolume0.00Open5.61Pre Close0.00Turnover0.00%Turnover Ratio16.70P/E (Static)1.50BShares6.3652wk High0.87P/B8.41BFloat Cap3.7952wk Low6.17Limit Up1.50BShs Float12.55Historical High5.05Limit Down0.00%Amplitude1.19Historical Low0.30Dividend TTM--Avg Price0lotAsk5.35%Div YieldTTM100Lot Size0lotBid
Bros Eastern Co.,Ltd Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 19.29%6.07B | 23.89%3.99B | 23.45%1.83B | -1.08%6.91B | -11.09%5.09B | -18.77%3.22B | -24.78%1.49B | -10.10%6.99B | 3.07%5.73B | 1.11%3.96B |
| Operating revenue | 19.29%6.07B | 23.89%3.99B | 23.45%1.83B | -1.08%6.91B | -11.09%5.09B | -18.77%3.22B | -24.78%1.49B | -10.10%6.99B | 3.07%5.73B | 1.11%3.96B |
| Other operating revenue | ---- | 49.29%317.97M | ---- | -21.42%457.24M | ---- | -35.76%212.99M | ---- | 58.38%581.88M | ---- | 142.61%331.54M |
| Total operating cost | 16.75%5.87B | 29.27%3.9B | 29.97%1.88B | 18.98%6.97B | 7.28%5.03B | -6.24%3.02B | -10.25%1.45B | -9.08%5.86B | -2.62%4.69B | -6.56%3.22B |
| Operating cost | 18.44%5.38B | 31.05%3.59B | 34.01%1.73B | 23.58%6.32B | 10.22%4.54B | -4.50%2.74B | -11.79%1.29B | -10.91%5.11B | -4.69%4.12B | -7.54%2.87B |
| Operating tax surcharges | -17.13%17.35M | -22.01%11.77M | -29.62%4.41M | -20.33%29.39M | -20.98%20.94M | -20.38%15.1M | -27.75%6.27M | -10.63%36.89M | 2.77%26.49M | 29.01%18.96M |
| Operating expense | 10.70%35.15M | 15.51%23.93M | -6.42%11.5M | -17.83%40.48M | -2.97%31.75M | -7.32%20.72M | 9.53%12.29M | 31.95%49.26M | 52.35%32.72M | 40.67%22.35M |
| Administration expense | -8.83%240.59M | -14.49%158.42M | -14.71%82.7M | -15.62%331.09M | 2.97%263.89M | 9.07%185.26M | 29.33%96.97M | 7.92%392.35M | -1.29%256.27M | 1.07%169.85M |
| Financial expense | 6.34%110.58M | 374.32%59.06M | 24.62%37.95M | -1.71%154.21M | -32.22%103.99M | -81.81%12.45M | -6.50%30.46M | 42.50%156.9M | 99.12%153.42M | 2.11%68.45M |
| -Interest expense (Financial expense) | -4.05%132.91M | 35.45%94.91M | 12.03%47.74M | 22.22%192.18M | 23.97%138.52M | 0.35%70.07M | 51.17%42.61M | 28.98%157.24M | 20.21%111.73M | 11.14%69.83M |
| -Interest Income (Financial expense) | -80.72%-52.89M | -108.31%-39.87M | -261.04%-11.39M | -144.09%-45.53M | -145.39%-29.27M | -236.79%-19.14M | -132.52%-3.15M | -489.00%-18.65M | -298.03%-11.93M | -221.91%-5.68M |
| Research and development | 32.56%87.64M | 29.18%58.71M | 37.70%19.86M | -11.19%100.28M | -32.27%66.11M | -36.05%45.45M | -45.29%14.42M | -27.20%112.91M | -7.76%97.62M | -7.72%71.07M |
| Credit Impairment Loss | 62.30%-467.33K | 102.76%61.75K | 182.00%4.55M | -178.91%-9M | -109.38%-1.24M | -128.47%-2.24M | -235.98%-5.55M | 579.61%11.41M | 637.48%13.22M | 1,118.43%7.85M |
| Asset Impairment Loss | ---- | ---- | ---1.23K | 87.81%-47.48M | 94.35%-1.23M | ---- | ---- | -782.60%-389.6M | -171.64%-21.72M | -58.69%-8.93M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---0.01 | ---- |
| Other net revenue | -54.21%245.52M | 64.77%172.35M | 254.44%165.6M | 5.78%645.26M | 334.81%536.22M | 26.54%104.6M | 637.38%46.72M | 328.58%610.02M | 22.45%123.32M | -7.51%82.66M |
| Fair value change income | 77.90%-4.67M | 33.47%-16.59M | 100.04%8.99K | -95.97%1.01M | ---21.15M | -4,048.66%-24.94M | ---22.87M | 3,859.40%25.19M | ---- | 472.40%631.59K |
| Invest income | -79.31%109.89M | -40.20%62.5M | -21.84%46.04M | -27.79%667.56M | 396.36%531.03M | 49.94%104.51M | 1,370.01%58.9M | 437.40%924.45M | 7.06%106.98M | -20.93%69.7M |
| -Including: Investment income associates | -11.50%64.69M | -53.84%18.73M | -24.13%36.8M | -38.34%106.69M | -4.11%73.1M | -34.74%40.56M | 842.75%48.51M | 36.56%173.04M | 9.50%76.23M | -10.71%62.16M |
| Asset deal income | 638.53%122.48M | 573.82%118.89M | 804.07%111.23M | 7.46%18.09M | 84.43%16.58M | 926.38%17.64M | 1,497.95%12.3M | 603.59%16.83M | 463.97%8.99M | 163.57%1.72M |
| Other revenue | 49.61%18.28M | -22.10%7.49M | -3.84%3.78M | -30.59%15.09M | -22.92%12.22M | -17.71%9.62M | -35.81%3.93M | 4.31%21.74M | 13.47%15.86M | 28.75%11.69M |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Operating profit | -25.28%445.9M | -15.22%259.43M | 39.54%117.26M | -66.22%587.78M | -48.58%596.77M | -63.01%306M | -77.14%84.03M | 18.18%1.74B | 37.97%1.16B | 46.62%827.19M |
| Add:Non operating Income | 5.72%9.52M | -43.73%4.16M | -75.65%1.17M | -28.13%13.69M | 60.52%9.01M | 317.64%7.39M | 320.17%4.81M | 202.48%19.04M | 11.50%5.61M | -61.00%1.77M |
| Less:Non operating expense | 124.20%4.19M | 124.40%3.53M | 656.84%9.43M | 1,248.20%17.4M | -72.41%1.87M | -5.17%1.57M | 61.87%1.25M | -85.07%1.29M | 43.01%6.77M | -57.28%1.66M |
| Total profit | -25.28%451.24M | -16.60%260.06M | 24.43%108.99M | -66.77%584.07M | -47.91%603.91M | -62.31%311.82M | -76.20%87.59M | 19.58%1.76B | 37.78%1.16B | 46.47%827.3M |
| Less:Income tax cost | -24.31%38.57M | -29.46%27.26M | 725.93%28.67M | -58.96%80.03M | -57.96%50.96M | -23.80%38.65M | -85.19%3.47M | 96.75%194.98M | 142.79%121.21M | 252.16%50.72M |
| Net profit | -25.37%412.67M | -14.78%232.8M | -4.51%80.33M | -67.75%504.04M | -46.74%552.95M | -64.82%273.17M | -75.59%84.12M | 14.00%1.56B | 31.16%1.04B | 41.09%776.58M |
| Net profit from continuing operation | -25.37%412.67M | -14.78%232.8M | -4.51%80.33M | -67.75%504.04M | -46.74%552.95M | -64.82%273.17M | -75.59%84.12M | 14.00%1.56B | 31.16%1.04B | 41.09%776.58M |
| Net profit of parent company owners | -25.37%412.67M | -14.78%232.8M | -4.51%80.33M | -67.75%504.04M | -46.74%552.95M | -64.82%273.17M | -75.59%84.12M | 14.00%1.56B | 31.16%1.04B | 41.09%776.58M |
| Earning per share | ||||||||||
| Basic earning per share | -24.32%0.28 | -11.11%0.16 | -16.67%0.05 | -67.92%0.34 | -47.14%0.37 | -66.04%0.18 | -73.91%0.06 | 13.98%1.06 | 29.63%0.7 | 43.24%0.53 |
| Diluted earning per share | -24.32%0.28 | -11.11%0.16 | -16.67%0.05 | -67.62%0.34 | -47.14%0.37 | -66.04%0.18 | -73.91%0.06 | 12.90%1.05 | 29.63%0.7 | 43.24%0.53 |
| Other composite income | -177.19%-112.51M | -179.27%-240.32M | 13.31%-94.33M | -124.75%-49.52M | -56.07%145.76M | 112.54%303.17M | -56.35%-108.81M | 1,101.81%200.08M | 347.91%331.81M | 1,710.61%142.64M |
| Other composite income of parent company owners | -177.19%-112.51M | -179.27%-240.32M | 13.31%-94.33M | -124.75%-49.52M | -56.07%145.76M | 112.54%303.17M | -56.35%-108.81M | 1,101.81%200.08M | 347.91%331.81M | 1,710.61%142.64M |
| Total composite income | -57.04%300.15M | -101.30%-7.52M | 43.27%-14.01M | -74.22%454.52M | -49.00%698.71M | -37.30%576.34M | -108.98%-24.69M | 27.06%1.76B | 58.26%1.37B | 69.73%919.22M |
| Total composite income of parent company owners | -57.04%300.15M | -101.30%-7.52M | 43.27%-14.01M | -74.22%454.52M | -49.00%698.71M | -37.30%576.34M | -108.98%-24.69M | 27.06%1.76B | 58.26%1.37B | 69.73%919.22M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.